We are live on
!
Find out more
SIC
SFE Investment Counsel Portfolio holdings
AUM
$742M
1-Year Est. Return
39.38%
This Fund
S&P 500
This Quarter
Est. Return
-19.24%
1 Year Est. Return
+39.38%
3 Year Est. Return
+105.37%
5 Year Est. Return
+137.02%
10 Year Est. Return
+468.73%
AUM
$182M
AUM Growth
-$62.5M
(-26%)
Cap. Flow
-$6.23M
Cap. Flow
% of AUM
-3.42%
Top 10 Holdings %
Top 10 Hldgs %
30.52%
Holding
113
New
–
Increased
40
Reduced
53
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oneok
OKE
|
+$2.03M |
| 2 |
BSJN
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
|
+$1.56M |
| 3 |
MSB
Mesabi Trust
MSB
|
+$1.34M |
| 4 |
BSJO
Invesco BulletShares 2024 High Yield Corporate Bond ETF
BSJO
|
+$1.06M |
| 5 |
Cleveland-Cliffs
CLF
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.91M |
| 2 |
Apple
AAPL
|
+$1.76M |
| 3 |
Costco
COST
|
+$1.59M |
| 4 |
WBA
Walgreens Boots Alliance
WBA
|
+$919K |
| 5 |
Northrop Grumman
NOC
|
+$913K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.31% |
| 2 | Healthcare | 13.55% |
| 3 | Industrials | 9.46% |
| 4 | Consumer Discretionary | 7.63% |
| 5 | Financials | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATRS
101
DELISTED
Antares Pharma, Inc.
ATRS
| $142K | 0.08% |
60,000
| – | – |
|
102
Albemarle
ALB
$15.5B
| – | – |
-3,855
| Closed | -$282K |
|
103
AZZ Inc
AZZ
$4.58B
| – | – |
-5,915
| Closed | -$272K |
|
104
DTE Energy
DTE
$28.5B
| – | – |
-2,350
| Closed | -$260K |
|
105
Columbia Emerging Markets Consumer ETF
ECON
$303M
| – | – |
-9,450
| Closed | -$222K |
|
106
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$585M
| – | – |
-6,600
| Closed | -$210K |
|
107
Helmerich & Payne
HP
$4.18B
| – | – |
-4,830
| Closed | -$219K |
|
108
Hexcel
HXL
$7.63B
| – | – |
-3,435
| Closed | -$252K |
|
109
MKS Inc
MKSI
$19.8B
| – | – |
-2,448
| Closed | -$269K |
|
110
Sempra
SRE
$55.1B
| – | – |
-4,330
| Closed | -$328K |
|
111
Williams-Sonoma
WSM
$29.5B
| – | – |
-11,524
| Closed | -$423K |
|
|
XYZ
112
Block Inc
XYZ
$47.5B
| – | – |
-3,335
| Closed | -$209K |
|
|
BEAT
113
DELISTED
BioTelemetry, Inc.
BEAT
| – | – |
-5,119
| Closed | -$237K |
|
Similar funds
HCP
KAM
SIA
HI
CC
PCOC
QI
CT
SFE Investment Counsel's Q1 2020 Portfolio in Review
As of Q1 2020, SFE Investment Counsel held 113 positions worth $182M, down 26% from $245M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
SFE Investment Counsel withdrew a net $6.23M in Q1 2020, closing 12 positions and reducing 53 holdings. Its most notable exit was Williams-Sonoma, an estimated $423K position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, SFE Investment Counsel added an estimated $2.03M to Oneok.
- SFE Investment Counsel added most to Oneok in Q1 2020, an estimated $2.03M increase.
- SFE Investment Counsel's biggest Q1 2020 reduction was Abbott, cutting an estimated $1.91M.
- SFE Investment Counsel fully exited Williams-Sonoma in Q1 2020, selling an estimated $423K.
- SFE Investment Counsel's ten largest holdings make up 31% of its $182M portfolio in Q1 2020.
- SFE Investment Counsel opened 0 new positions and closed 12 in Q1 2020.
- SFE Investment Counsel's portfolio value fell 26% quarter-over-quarter to $182M.
Based on SFE Investment Counsel's 13F filing for Q1 2020, filed 4 May 2020.